HIV, Late presentation, Microbiota, Antiretroviral therapy, dolutegravir
HIV, Late presentation, microbiota, antiretroviral therapy, Dolutegravir
CD8+ resident memory T cells, female genital tract, HIV persistence, cervical explant model, HIV reservoirs, immune checkpoint receptors, PD-1, CD39, polyfunctional, degranulation, IL-15, TGF-β1, homing